XML 57 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The income tax (benefit) provision consisted of the following (in thousands):
 
Current
 
Deferred
 
Total
Year ended December 31, 2019
 
 
 
 
 
Federal
$
(61,951
)
 
$
195

 
$
(61,756
)
State
509

 
30

 
539

Foreign
—

 
209

 
209

 
$
(61,442
)
 
$
434

 
$
(61,008
)
Year ended December 31, 2018
 

 
 

 
 

Federal
$
2,768

 
$
(40,345
)
 
$
(37,577
)
State
(1,677
)
 
(2,093
)
 
(3,770
)
Foreign
32

 
5,042

 
5,074

 
$
1,123

 
$
(37,396
)
 
$
(36,273
)
Year ended December 31, 2017
 

 
 

 
 

Federal
$
78,806

 
$
(105,006
)
 
$
(26,200
)
State
1,706

 
(9,785
)
 
(8,079
)
Foreign
89

 
(458
)
 
(369
)
 
$
80,601

 
$
(115,249
)
 
$
(34,648
)


Schedule of Effective Income Tax Rate Reconciliation
The income tax provision differs from the “expected” tax expense computed by applying the U.S. Federal corporate income tax rates of 21% to loss before income taxes, as follows (in thousands):
 
Years Ended December 31,
 
2019
 
2018
 
2017
Computed “expected” tax provision
$
(60,433
)
 
$
(92,018
)
 
$
(20,719
)
Change in income taxes resulting from:
 
 
 
 
 
State income taxes, net of Federal income tax
(7,402
)
 
(11,667
)
 
(537
)
Change in state income tax rate, net of Federal income tax
728

 
(16
)
 
(4,714
)
Foreign income tax (benefit) provision
(2,623
)
 
(1,658
)
 
2,206

Deduction for domestic production activities
—

 
—

 
(2,527
)
Stock compensation
4,565

 
2,480

 
(1,316
)
R&D tax credits
(1,428
)
 
(750
)
 
(1,200
)
Nondeductible acquisition fees
—

 
(1,165
)
 
1,974

Uncertain tax positions
(47,357
)
 
7,935

 
15,650

Federal rate change
—

 
(3,027
)
 
(26,902
)
Lapse of statute of limitations
(16,034
)
 
570

 
1,561

Taxes receivable true up
2,651

 
—

 
—

Deferred tax adjustment
17,578

 
—

 
—

162(m) Officers Compensation Limitation
340

 
1,483

 
—

Other expense, net
408

 
934

 
1,201

Valuation allowance change
47,999

 
60,626

 
675

Income tax (benefit)
$
(61,008
)
 
$
(36,273
)
 
$
(34,648
)

Schedule of Income before Income Tax, Domestic and Foreign
The geographic allocation of the Company’s income before income taxes between U.S. and foreign operations was as follows (in thousands):
 
2019
 
2018
 
2017
Pre-tax (loss) from U.S. operations
$
(237,474
)
 
$
(428,299
)
 
$
(49,572
)
Pre-tax (loss) from foreign operations
(50,304
)
 
(9,883
)
 
(9,626
)
Total pre-tax (loss)
$
(287,778
)
 
$
(438,182
)
 
$
(59,198
)


Schedule of Deferred Tax Assets and Liabilities
Net deferred income taxes at December 31, 2019 and 2018 include (in thousands):
 
December 31,
 
2019
 
2018
Deferred tax assets:
 
 
 
Net operating loss carry-forward
$
51,125

 
$
48,766

Stock-based compensation
8,912

 
9,071

Chargeback reserves
3,336

 
14,173

Reserve for product returns
8,001

 
8,012

Inventory valuation reserve
8,423

 
9,688

Legal reserve
15,294

 
—

Long-term debt
56,117

 
16,156

Other
16,793

 
16,444

Total deferred tax assets
$
168,001

 
$
122,310

Valuation allowance
(119,156
)
 
(71,157
)
Net deferred tax assets
$
48,845

 
$
51,153

Deferred tax liabilities:
 

 
 

Prepaid expenses
$
(2,190
)
 
$
(2,137
)
 Right of Use Asset
(5,311
)
 
—

Depreciation & amortization – tax over book
(41,534
)
 
(49,547
)
Other
$
(35
)
 
$
(35
)
Total deferred tax liabilities
$
(49,070
)
 
$
(51,719
)
Net deferred income tax (liability)
$
(225
)
 
$
(566
)

Schedule of Unrecognized Tax Benefits Roll Forward  

Based on its review as of December 31, 2019, the Company determined that it would not recognize tax benefits as follows (in thousands): 
Balance at December 31, 2016
$
1,301

Additions relating to 2017
416

Additions relating to prior years
$
24,297

Reductions of exposures relating to prior years
(619
)
Balance at December 31, 2017
$
25,395

Additions relating to 2018
269

Additions relating to prior years
4,425

Reductions of exposures relating to prior years
(702
)
Balance at December 31, 2018
$
29,387

Reductions of exposures relating to prior years
(26,992
)
Lapse of statute of limitations
$
(33
)
Balance at December 31, 2019
$
2,362